NEW YORK: The Lupus Initiative has hired Kyne following a competitive RFP process to promote its new curriculum for US medical professionals.
The Lupus Initiative is an educational program led by the American College of Rheumatology and funded in part by the US Department of Health & Human Services' Office of Minority Health.
Lupus is an autoimmune disease, in which the body's immune system creates antibodies that can attack any organ in the body. Most lupus sufferers are women between the ages of 15 and 44. Women of color are two to three-times at greater risk than white women.
In March, as part of the Consolidated and Further Continuing Appropriations Act, Congress granted $1 million for The Lupus Initiative, the education program launched in 2010 to educate healthcare professionals, educators, and students about diagnosing and treating lupus.
Kyne's scope of work includes drawing attention to a Washington DC event on May 16 where the group will unveil a comprehensive curriculum designed to ensure that every healthcare professional recognizes and understands this illness. Its ultimate goal is to improve health outcomes.
Kyne expects to continue supporting the organization through material development and traditional and social media outreach following the event.
The initiative is crucial “as the symptoms for Lupus can be confused with other things,” said Tegwyn Collins, senior director at Kyne, who is leading the work.
“We hope to elevate awareness to help catch the disease earlier, leading to better quality of life,” she said.
A representative from The Lupus Initiative was not immediately available for comment.
Gradian Health Systems, a nonprofit social enterprise, also recently selected Kyne to lead strategic communications efforts on behalf of the organization as it seeks to improve access to safe surgery and preoperative care in developing countries.
The company designs and builds anesthetic equipment used worldwide in hospitals ranging from world-renowned academic centers to resource-constrained district facilities.
A representative from Gradian was unavailable for comment.